IceCure Medical Ltd. (ICCM)
Total Valuation
ICCM has a market cap or net worth of $67.98 million. The enterprise value is $46.47 million.
| Market Cap | 67.98M |
| Enterprise Value | 46.47M |
Important Dates
The latest earnings date was Wednesday, May 18, 2022, before market open.
| Last Earnings Date | May 18, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
ICCM has 35.78 million shares outstanding. The number of shares has increased by 77.51% in one year.
| Shares Outstanding | 35.78M |
| Shares Change (YoY) | +77.51% |
| Shares Change (QoQ) | +11.90% |
| Owned by Insiders (%) | 73.44% |
| Owned by Institutions (%) | 9.21% |
| Float | 9.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.71 |
| PB Ratio | 2.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.40, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.40 |
| Quick Ratio | 4.61 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $71,854 |
| Profits Per Employee | -$270,229 |
| Employee Count | 48 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | 1.78 |
| Total Price Change | -84.01% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 3.12 |
| Average Volume (30 Days) | 25,916 |
Short Selling Information
The latest short interest is 91,734, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 91,734 |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.97% |
| Short Ratio (days to cover) | 4.09 |
Income Statement
In the last 12 months, ICCM had revenue of $3.45 million and -12.97 million in losses. Earnings per share was -$0.35.
| Revenue | 3.45M |
| Gross Profit | n/a |
| Operating Income | n/a |
| Net Income | -12.97M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | -$0.35 |
Balance Sheet
The company has $22.36 million in cash and $847,000 in debt, giving a net cash position of $21.51 million or $0.60 per share.
| Cash & Cash Equivalents | 22.36M |
| Total Debt | 847,000 |
| Net Cash | 21.51M |
| Net Cash Per Share | $0.60 |
| Book Value | 22.96M |
| Book Value Per Share | 0.64 |
| Working Capital | 21.74M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | -376.08% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -19.08% |
| FCF Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
Analyst Forecast
The average price target for ICCM is $0.02, which is -98.95% lower than the current price. The consensus rating is "Buy".
| Price Target | $0.02 |
| Price Target Difference | -98.95% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on August 9, 2021. It was a reverse split with a ratio of 1:8.
| Last Split Date | Aug 9, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:8 |